ArticleThe American journal of gastroenterology2015

Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: a useful cutoff in clinical practice.

Giorgia Bodini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.